TY - JOUR T1 - Treatment of orbital myositis with adalimumab (Humira). JF - The Journal of Rheumatology JO - J Rheumatol SP - 1374 LP - 1375 VL - 32 IS - 7 AU - Alexa B Adams AU - Michael Kazim AU - Thomas J A Lehman Y1 - 2005/07/01 UR - http://www.jrheum.org/content/32/7/1374.abstract N2 - Adalimumab is a fully humanized IgG1 monoclonal antibody to tumor necrosis factor-a. We describe 2 patients (17 and 13 years of age) with refractory, steroid-dependent, recurrent nonspecific orbital myositis not controlled with standard immunosuppressive medications. Both improved with adalimumab treatment, allowing reduction in corticosteroid dosage without disease flare. ER -